IRIS
RIGAMONTI, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.599
NA - Nord America 2.079
AS - Asia 1.764
SA - Sud America 441
AF - Africa 94
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.975
IE - Irlanda 745
SG - Singapore 597
IT - Italia 521
BR - Brasile 329
HK - Hong Kong 317
DE - Germania 296
SE - Svezia 291
VN - Vietnam 206
CN - Cina 204
RU - Federazione Russa 198
UA - Ucraina 183
IN - India 117
FI - Finlandia 79
ID - Indonesia 70
FR - Francia 69
CA - Canada 66
GB - Regno Unito 66
KR - Corea 65
AR - Argentina 42
TR - Turchia 38
BJ - Benin 32
IR - Iran 28
NL - Olanda 28
MX - Messico 26
AT - Austria 24
ZA - Sudafrica 23
BD - Bangladesh 22
CZ - Repubblica Ceca 21
PK - Pakistan 20
PL - Polonia 20
JP - Giappone 19
EC - Ecuador 18
ES - Italia 18
CL - Cile 15
MY - Malesia 13
AU - Australia 12
PE - Perù 11
PY - Paraguay 9
CH - Svizzera 8
KE - Kenya 8
VE - Venezuela 8
BE - Belgio 7
EG - Egitto 7
IQ - Iraq 7
LT - Lituania 7
MA - Marocco 7
CO - Colombia 6
IL - Israele 6
NG - Nigeria 6
TH - Thailandia 6
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
MO - Macao, regione amministrativa speciale della Cina 4
PH - Filippine 4
DZ - Algeria 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
RO - Romania 3
SA - Arabia Saudita 3
UY - Uruguay 3
AZ - Azerbaigian 2
CU - Cuba 2
DK - Danimarca 2
GA - Gabon 2
LB - Libano 2
LY - Libia 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
KH - Cambogia 1
MK - Macedonia 1
MT - Malta 1
NP - Nepal 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
Totale 6.992
Salva come PNG Salva come JPEG
Città #
Dublin 733
Jacksonville 308
Hong Kong 302
Singapore 214
Ashburn 159
Beijing 114
Chandler 99
Lawrence 82
Princeton 82
Los Angeles 76
Moscow 73
Wilmington 71
San Mateo 69
Novara 63
Ho Chi Minh City 56
Jakarta 55
Dearborn 54
Seoul 53
Munich 52
Piemonte 49
Milan 41
Hanoi 40
Helsinki 40
New York 40
Buffalo 37
Dong Ket 36
Turin 36
São Paulo 34
Cotonou 32
Chennai 28
Bremen 27
Dallas 26
Montreal 26
Ann Arbor 25
Nuremberg 25
Vercelli 25
Redondo Beach 24
Frankfurt am Main 23
Andover 21
Boardman 21
Santa Clara 20
Brno 19
Denver 17
Orem 17
Toronto 17
Warsaw 17
Brooklyn 16
Johannesburg 16
Norwalk 16
London 15
Stockholm 14
Monmouth Junction 13
Vienna 13
Poplar 12
Boston 11
Falkenstein 11
Houston 11
Istanbul 11
Mexico City 11
Rome 11
Tokyo 11
Ankara 10
Augusta 10
Kocaeli 10
Rio de Janeiro 10
West Jordan 10
Amsterdam 9
Ardabil 9
Atlanta 9
Bologna 9
Santiago 9
Alessandria 8
Fairfield 8
Mumbai 8
Nairobi 8
Nanjing 8
Seattle 8
Turku 8
Brasília 7
Brussels 7
Chicago 7
Da Nang 7
Dhaka 7
Mülheim 7
Philadelphia 7
Phoenix 7
Porto Alegre 7
Royal Leamington Spa 7
Salvador 7
Sham Shui Po 7
Tianjin 7
Woodbridge 7
Asunción 6
Goioerê 6
Guayaquil 6
Haiphong 6
Hải Dương 6
Lagos 6
Leawood 6
Manchester 6
Totale 3.967
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 330
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 204
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 149
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 143
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 138
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 122
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 120
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 119
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 115
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 111
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 108
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 103
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 100
Chronic hepatitis C is mild in menstruating women 97
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 95
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 94
Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids 89
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 88
Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C 87
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 86
Coronavirus Disease 2019 (COVID‐19) in autoimmune hepatitis: a lesson from immunosuppressed patients 86
CYP2E1 autoantibodies in liver diseases 84
Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study 83
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 81
Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C 79
Elastography in Liver-Transplanted Patients 79
Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019 79
Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome 77
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 77
Giant liver fibrous tumours metastatic from atypical recurrent meningeal neoplasia 76
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 76
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 75
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 73
Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes 72
Authors’ response re: “The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs” 72
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 72
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases 71
Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C 70
Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients 70
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 69
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 68
Adequate vs. deep response to UDCA in PBC: To what extent and under what conditions is normal ALP level associated with complication-free survival gain? 68
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis 68
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: Results from a 29-year cohort study 67
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges 65
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury 65
Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method 63
Outcome of COVID-19 in Patients with Autoimmune Hepatitis: an International Multi-Centre Study 62
Severe thombocytopenia and clinical bleeding associated with rituximab infusion in a lynphoma patient with massive splenomegaly without leukemic invasion 59
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 58
Gender and liver fibrosis in chronic hepatitis: the role of iron status 58
Can protocol liver biopsy be avoided to evaluate post-transplant hepatitis C recurrence? Transient elastography makes it possible 56
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 56
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 55
Spleen Stiffness Measured by Transient Elastography Accurately Predicts Esophageal Varices in Liver Cirrhosis 54
Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C 54
Transjugular liver biopsy: The Tru-cut needle might be better for stiffer livers 54
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 52
Hepatocellular carcinoma after direct-acting antiviral agents: Can liver stiffness kinetics help identify patients at lower risk? 51
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipients 51
Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion 51
SURVIVAL FOLLOWING THE DEVELOPMENT OF ASCITES AND/OR PERIPHERAL OEDEMA IN PRIMARY BILIARY CIRRHOSIS: A STAGED PROGNOSTIC MODEL 51
Transient elastography in the assessment of liver fibrosis in adult thalassemia patients 51
Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years 50
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 50
Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation 49
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy 49
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 48
Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach 48
Diagnosis of cirrhosis by transient elastography: what is hidden behind misleading results 48
Do not trivialize the Fibroscan® examination, value its accuracy 48
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C 48
Iron, hepatic stellate cells and fibrosis in chronic hepatitis C 47
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 47
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 47
The evolving landscape of autoimmune hepatitis: an ambispective cohort study 46
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial 46
ERCP and short-term stent-trial in patients with anastomotic biliary stricture following liver transplantation 46
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease 46
Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease 45
Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C 45
Emerging Issues in the Immunopathogenesis, Diagnosis and Clinical Management of Primary Biliary Cirrhosis Associated with Systemic Sclerosis 45
LIVER BIOPSY TECHNIQUES: AUTOMATED ASPIRATION NEEDLES PROVIDE ADEQUATE TISSUE SAMPLES 44
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 44
High prevalence of acute onset autoimmune hepatitis in males: A real-life cohort from Northern Italy 44
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 44
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis 43
Long term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years 43
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 43
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 42
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation 42
Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study 39
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 38
Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsy 37
Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation 37
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis 36
Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis 36
Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation 36
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 34
Might rapid virological response be used as a stopping rule in liver transplant recipients treated with pegylated interferon plus ribavirin? 33
Totale 6.969
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021336 0 0 0 0 0 21 71 11 79 31 81 42
2021/2022613 17 47 79 44 38 17 43 20 60 37 82 129
2022/20231.418 155 84 70 19 69 87 56 60 718 19 48 33
2023/2024767 38 61 43 23 107 38 142 60 28 42 54 131
2024/20251.568 30 25 110 41 56 158 215 177 324 102 67 263
2025/20261.874 203 169 310 685 454 53 0 0 0 0 0 0
Totale 7.192